E-Poster - S3
Symposium 3: “Transcription/Translation
Chairs:
Javier León. IBBTEC. Cantabria. Spain
Javier Martínez-Useros. University Hospital "Fundacion Jimenez Diaz". Spain
Javier León. IBBTEC. Cantabria. Spain
Javier Martínez-Useros. University Hospital "Fundacion Jimenez Diaz". Spain
Activity of CDK9 PROTAC (THAL-SNS-032) in HER2 positive breast cancer (ID_ 19)
Noblejas-López MDM1, Gandullo-Sánchez L2, Galán-Moya EM1,3, López-Rosa R1, Tébar-García D1, Nieto-Jiménez C1, Burgos M1, Pandiella 2, and Ocana A1,4
1 Translational Oncology Laboratory, Centro Regional de Investigaciones Biomédicas, Castilla‐La Mancha University (CRIB‐UCLM), Albacete, Castilla-La Mancha, Spain; 2 Instituto de Biología Molecular y Celular del Cáncer and CIBERONC. CSIC Salamanca, Castilla y León, Spain; 3 Faculty of Nursing, Castilla-La Mancha University (UCLM), Albacete, Spain; 4 Hospital Clínico Universitario San Carlos, IDISSC and CIBERONC, Madrid, Spain.